Loading clinical trials...
Loading clinical trials...
This study is to provide access for patients who are receiving treatment with dabrafenib and/or trametinib in a Novartis-sponsored Oncology Global Development, Global Medical Affairs or a former GSK-s...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Pharmaceuticals
NCT07589530 · Advanced Solid Tumors, Metastatic Solid Tumors, and more
NCT06312137 · Non Small Cell Lung Cancer
NCT07042100 · Advanced Solid Tumors
NCT06594991 · Advanced Melanoma
NCT07224425 · Solid Tumours, Melanoma
Honor Health Research Institute
Scottsdale, Arizona
Honor Health Research Institute
Scottsdale, Arizona
National Institute Of Health
Bethesda, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions